Transit agency sues Gilead over pricing of hepatitis C drug

December 11, 2014 4:53 AM

3 0

Transit agency sues Gilead over pricing of hepatitis C drug

The lawyers for the Southeastern Pennsylvania Transportation Authority, or SEPTA, announced on Wednesday that they have filed a lawsuit against Gilead Sciences challenging the "exorbitant pricing" of its hepatitis C drug, Sovaldi.

The release from Philadelphia's transit agency said that Gilead has been selling a 12-week dose of Sovaldi in the United States for about $84,000, or $1,000 a pill, far above its price in other countries and the original projected price.

Read more

To category page

Loading...